340B Spotlight: Audit Findings Show Importance of Increased Oversight of 340B Program

PhRMA commented on Health Resources and Services Administration (HRSA) audits of 340B covered entities and the importance of oversight in the 340B program. The article cited HRSA audit findings and focused on the issues of diversion and duplicate discounts, stating “more than 60 percent of the DSH hospitals audited had incidents of diversion, while nearly a quarter of the DSH hospitals audited had incidents of duplicate discounts.” With the growth of the 340B program they emphasize that “ensuring entities are compliant with its rules is of the utmost importance.”